Wanze Shuangqi Pharmaceutical

Wanze Shuangqi Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and production of micro-ecological medicines and probiotic-based therapies. The company is best known for its flagship product, Bifidobacterium tetravaccine (Live), marketed under the brand name Shuangqi, which is used to treat intestinal flora imbalance and various gastrointestinal disorders. Operating as a core subsidiary of the publicly traded Wanze Co., Ltd., the firm maintains large-scale GMP-certified manufacturing facilities in Shenzhen and Inner Mongolia. Wanze Shuangqi focuses on leveraging microbial technology to address unmet needs in digestive health and has established a dominant position in the Chinese domestic market for live biotherapeutic products.